(Q34221475)

31 July 2017

title

Serum FGF-21 levels in type 2 diabetic patients (English)

1 reference

31 July 2017

Xingbo Cheng

1

1 reference

31 July 2017

Bei Zhu

series ordinal

2

1 reference

31 July 2017

Fusong Jiang

series ordinal

3

1 reference

31 July 2017

Huaying Fan

series ordinal

4

1 reference

31 July 2017

publication date

1 January 2011

1 reference

31 July 2017

1 reference

31 July 2017

volume

36

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

142-148

1 reference

Fibroblast growth factors, their receptors and signaling

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2011.558550

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2011.558550

Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2011.558550

Evolution of the Fgf and Fgfr gene families

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2011.558550

FGF-21 as a novel metabolic regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2011.558550

The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2011.558550

A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2011.558550

Identification of a novel FGF, FGF-21, preferentially expressed in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2011.558550

Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2011.558550

PPARalpha is a key regulator of hepatic FGF21.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2011.558550

Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2011.558550

Molecular determinants of FGF-21 activity-synergy and cross-talk with PPARgamma signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2011.558550

Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2011.558550

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2011.558550

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2011.558550

Structural basis for fibroblast growth factor receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2011.558550

BetaKlotho is required for metabolic activity of fibroblast growth factor 21

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2011.558550

Plasma FGF-21 levels in type 2 diabetic patients with ketosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2011.558550

Circulating FGF-21 levels in normal subjects and in newly diagnose patients with Type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2011.558550

The role of leptin in leptin resistance and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2011.558550

Serum levels of the adipokine FGF21 depend on renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2011.558550

Different roles of N- and C- termini in the functional activity of FGF21

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2011.558550

FGF21 N- and C-termini play different roles in receptor interaction and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2011.558550

10.3109/07435800.2011.558550

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference